In accordance with a recent (but smaller) real-world population study,42 we observed poor correlation between Ki67 and ROR score among tumours with intermediate Ki67 (i.e. uncertain chemotherapy candidates), but also in the other clinical risk groups. The gene discussed is MKI67; the disease is neoplasm.